kynurenine metabolism inhibitors (Kymo Therapeutics)

N/A

Report date: 2025/03/20 16:13:04
NME

Base Information

Drug Namekynurenine metabolism inhibitors (Kymo Therapeutics)
Drug Alias Namekynurenine monoxygenase inhibitors (Kymo Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKynurenine 3-monooxygenase inhibitors
TargetsKynurenine 3-monooxygenase
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetabrain Research
China Registration ClassN/A

Develop Information

Active CompaniesKymo Therapeutics Ltd
Inactive CompaniesMetabrain Research
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A